INC Research Holdings, Inc. (NASDAQ:INCR) CFO Gregory S. Rush sold 9,703 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $54.48, for a total value of $528,619.44. Following the completion of the sale, the chief financial officer now owns 78,593 shares of the company’s stock, valued at $4,281,746.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of INC Research Holdings, Inc. (NASDAQ INCR) opened at 52.30 on Thursday. The stock’s 50 day moving average price is $56.00 and its 200-day moving average price is $52.66. The firm has a market cap of $2.83 billion, a P/E ratio of 32.05 and a beta of 1.41. INC Research Holdings, Inc. has a 12 month low of $40.65 and a 12 month high of $61.10.
INC Research Holdings (NASDAQ:INCR) last released its earnings results on Thursday, July 27th. The company reported $0.64 EPS for the quarter, hitting analysts’ consensus estimates of $0.64. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The firm had revenue of $258.10 million during the quarter, compared to analyst estimates of $256.76 million. During the same quarter in the previous year, the business earned $0.61 EPS. The business’s quarterly revenue was down .3% compared to the same quarter last year. Equities research analysts anticipate that INC Research Holdings, Inc. will post $2.62 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://sportsperspectives.com/2017/09/21/gregory-s-rush-sells-9703-shares-of-inc-research-holdings-inc-incr-stock.html.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in INC Research Holdings by 14.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after acquiring an additional 228 shares during the period. Invictus RG acquired a new stake in INC Research Holdings during the 1st quarter worth $115,000. Pacad Investment Ltd. acquired a new stake in INC Research Holdings during the 2nd quarter worth $123,000. Foresters Investment Management Company Inc. acquired a new stake in INC Research Holdings during the 1st quarter worth $128,000. Finally, Riverhead Capital Management LLC acquired a new stake in INC Research Holdings during the 2nd quarter worth $128,000. 98.97% of the stock is owned by hedge funds and other institutional investors.
A number of equities research analysts have weighed in on INCR shares. SunTrust Banks, Inc. upgraded INC Research Holdings from a “hold” rating to a “buy” rating and upped their target price for the stock from $48.00 to $67.00 in a research report on Wednesday, May 31st. KeyCorp upgraded INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 price objective for the company in a research report on Monday, June 5th. Jefferies Group LLC reiterated a “buy” rating and set a $62.00 price objective on shares of INC Research Holdings in a research report on Friday, June 16th. William Blair downgraded INC Research Holdings from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 20th. Finally, BidaskClub downgraded INC Research Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $63.79.
INC Research Holdings Company Profile
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.